New to the Huntington's Disease Lighthouse?
 Welcome to the HDlighthouse!
 Getting started.
 
Home \ Research \ General \ Updates
Restorative Neuroscience

HD Lighthouse Contributing Editor's Comment: 

The HD Lighthouse will continue to offer a beacon of hope to families coping with Huntington's Disease until all of our ships are home safe in harbor. That means that just preventing and treating Huntington's will not be enough. We need restorative technologies.

Research with conditional mouse models has been encouraging.  When mice are engineered so that the HD gene can be turned off, they recover quite a bit, even late in the disease.  Still, people who are well into the disease process, will most likely need restorative technologies to recover fully.

This review essay by Scandavian researchers provides a helpful overview of the progress made towards making these technologies available and the issues that still need to be resolved. 

 

-- Marsha L. Miller, Ph.D.
Posted to the HDL: 03-28-2008

Restorative Neuroscience: Concepts and Perspectives

Robert Andres, Morton Meyer, Angelique Ducray, and Hans Widmer

There is increasing interest in the search for therapeutic options for diseases and injuries of the central nervous system (CNS), for which currently no effective treatment strategies are available. Replacement of damaged cells and restoration of function can be accomplished by transplantation of cells derived from different sources, such as human foetal tissue, genetically modified cell lines, embryonic or somatic stem cells. Preclinical and clinical trials have shown promising results in neurodegenerative disorders, like Parkinson’s and Huntington’s disease, but also ischaemic stroke, intracerebral haemorrhage, demyelinating disorders, epilepsy and traumatic lesions of the brain and spinal cord. Other studies have focused on finding new ways to activate and direct endogenous repair mechanisms in the CNS, eg, by exposure to specific neuronal growth factors or by inactivating inhibitory molecules. Neuroprotective drugs may offer an additional tool for improving neuronal survival in acute or chronic CNS diseases. Importantly however, a number of scientific issues need to be addressed in order to permit the introduction of these experimental techniques in the wider clinical setting.

# # #

Source: Swiss Medical Weekly 2008;138:155–172

print this
printer friendly
version

 

Read the HDLighthouse Forum. Post your comments
   
Related Topics
Research focusing on the formation of aggregates caused by HD
 
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
 
Research related HD and it's general affect on the brain
 
Learn more about the clinical trial process, trials that have been conducted and those that are underway.
 
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
 
Research focusing on gene therapy.
 
Research focusing on gene transcription.
 
Research studying the genetics of Huntington's Disease
 
Research studying the Immune System and it's effect on the progression of HD
 
Research studying the brain tissue and research related to stem cells
 

Recent Updates
25 Jul 2010
Sirtuin Inhibition Achieves Neuroprotection by Decreasing Sterol Biosynthesis
SIRT2 inhibition emerges as a promising therapeutic strategy.
 
24 May 2010
Cargo Recognition is Impaired in HD
Autophagy increases but is impaired, leading to an increase of the HD protein in the cytosol.
 
22 Dec 2009
Invitation to participate in a quality of life survey
Here is an opportunity to tell the medical professionals about quality of life issues.
 
6 Dec 2009
An interview with Dr. Jan Nolta
A trial of mesenchymal stem cell is planned for the end of 2010.
 
5 Dec 2009
Mesenchymal stem cells repair neurotoxin damage in an animal model
Preclinical work supports the use of mesenchymal stem cells to treat neurodegenerative disorders.
 
5 Dec 2009
The search for genetic modifiers
The search for genetic modifiers is an important part of the effort to find treatments.
 
20 Sep 2009
Axonal transport impaired in HD
Researchers have identified the mechanism by which axonal transport is impaired in neurons in HD.
 
4 Jul 2009
Rhes and the HD protein
Researchers at Johns Hopkins have discovered that a protein called rhes binds to the HD protein and causes toxicity.
 
24 Apr 2009
Acetylation of the HD protein
MSG-MIND researchers discover a new therapeutic target: increased acetylation enhances clearance of the HD ptotein from the nucleus.
 
31 Jan 2009
Impaired ERAD and ER stress
Cell model study shows that impaired ERAD and ER stress are early and specific events in polyglutamine toxicity.
 

All Updates for General
Disclaimer & Privacy Policy | Welcome | Site Feedback Marsha@HDLighthouse.org